P. J. Provost

3.3k total citations
40 papers, 2.4k citations indexed

About

P. J. Provost is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, P. J. Provost has authored 40 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 28 papers in Hepatology and 18 papers in Infectious Diseases. Recurrent topics in P. J. Provost's work include Hepatitis Viruses Studies and Epidemiology (28 papers), Hepatitis B Virus Studies (20 papers) and Viral gastroenteritis research and epidemiology (16 papers). P. J. Provost is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (28 papers), Hepatitis B Virus Studies (20 papers) and Viral gastroenteritis research and epidemiology (16 papers). P. J. Provost collaborates with scholars based in United States and Israel. P. J. Provost's co-authors include M. R. Hilleman, William J. Miller, V. M. Villarejos, O. L. Ittensohn, Barbara J. Kuter, W. J. McAleer, M. R. Hilleman, Gary Calandra, John A. Lewis and David R. Nalin and has published in prestigious journals such as New England Journal of Medicine, PEDIATRICS and Journal of Virology.

In The Last Decade

P. J. Provost

40 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. J. Provost United States	21	1.6k	1.5k	1.0k	274	264	40	2.4k
Gert Frösner Germany	31	1.9k 1.2×	2.1k 1.4×	854 0.8×	221 0.8×	124 0.5×	89	2.8k
Shin Isomura Japan	21	1.3k 0.8×	537 0.3×	999 1.0×	477 1.7×	547 2.1×	81	2.4k
Leonard N. Binn United States	32	1.0k 0.6×	1.1k 0.7×	1.9k 1.8×	436 1.6×	519 2.0×	89	2.7k
Howard A. Fields United States	34	1.9k 1.2×	2.9k 1.9×	1.6k 1.5×	367 1.3×	291 1.1×	115	3.7k
Karen A. McCaustland United States	29	1.6k 1.0×	1.9k 1.2×	1.7k 1.7×	316 1.2×	293 1.1×	44	3.6k
S. A. Plotkin United States	22	1.5k 0.9×	168 0.1×	1.1k 1.1×	347 1.3×	324 1.2×	55	2.3k
William H. Bancroft United States	27	1.1k 0.7×	952 0.6×	892 0.9×	242 0.9×	52 0.2×	68	2.2k
Gilberto Vaughan Mexico	21	785 0.5×	969 0.6×	858 0.8×	195 0.7×	102 0.4×	63	1.8k
Assad Safary Belgium	35	2.4k 1.5×	2.6k 1.7×	1.3k 1.2×	138 0.5×	47 0.2×	82	3.5k
Pierre Gallian France	31	769 0.5×	1.5k 1.0×	2.3k 2.2×	170 0.6×	428 1.6×	104	3.5k

Countries citing papers authored by P. J. Provost

Since Specialization

Citations

This map shows the geographic impact of P. J. Provost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. J. Provost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. J. Provost more than expected).

Fields of papers citing papers by P. J. Provost

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. J. Provost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. J. Provost. The network helps show where P. J. Provost may publish in the future.

Co-authorship network of co-authors of P. J. Provost

This figure shows the co-authorship network connecting the top 25 collaborators of P. J. Provost. A scholar is included among the top collaborators of P. J. Provost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. J. Provost. P. J. Provost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lemon, Stanley M., Paula C. Murphy, P. J. Provost, et al.. (1997). Immunoprecipitation and Virus Neutralization Assays Demonstrate Qualitative Differences between Protective Antibody Responses to Inactivated Hepatitis A Vaccine and Passive Immunization with Immune Globulin. The Journal of Infectious Diseases. 176(1). 9–19. 32 indexed citations

Krah, David L., P. J. Provost, & Ronald Ellis. (1995). Combined use of complement and anti-immunoglobulin in an enhanced neutralization assay for antibodies to varicella-zoster virus. Journal of Virological Methods. 53(2-3). 176–187. 9 indexed citations

Werzberger, Alan, Barbara J. Kuter, Daniel Shouval, et al.. (1993). Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial. Journal of Hepatology. 18. S46–S50. 11 indexed citations

Nalin, David R., Barbara J. Kuter, Leora Brown, et al.. (1993). Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. Journal of Hepatology. 18. S51–S55. 58 indexed citations

Armstrong, Marcy E., Joseph P. Davide, Julie A. Waterbury, et al.. (1993). Development of the formalin-inactivated hepatitis A vaccine, VAQTATM from the live attenuated virus strain CR326F. Journal of Hepatology. 18. S20–S26. 39 indexed citations

Werzberger, Alan, Barbara Mensch, Barbara J. Kuter, et al.. (1992). A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children. New England Journal of Medicine. 327(7). 453–457. 389 indexed citations

Ellerbeck, Edward F., John A. Lewis, David R. Nalin, et al.. (1992). Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A. Vaccine. 10(10). 668–672. 22 indexed citations

White, C. J., Barbara J. Kuter, Angela Ngai, et al.. (1992). Modified cases of chickenpox after varicella vaccination. The Pediatric Infectious Disease Journal. 11(1). 19–22. 157 indexed citations

White, C. J., Barbara J. Kuter, Catherine Hildebrand, et al.. (1991). Varicella Vaccine (VARIVAX) in Healthy Children and Adolescents: Results From Clinical Trials, 1987 to 1989. PEDIATRICS. 87(5). 604–610. 192 indexed citations

10.

Krah, Donatus, Raju D. Amin, David R. Nalin, & P. J. Provost. (1991). A Simple Antigen-Reduction Assay for the Measurement of Neutralizing Antibodies to Hepatitis A Virus. The Journal of Infectious Diseases. 163(3). 634–637. 15 indexed citations

11.

Provost, P. J., et al.. (1991). Further evaluation of a live hepatitis A vaccine in marmosets. Journal of Medical Virology. 34(4). 227–231. 9 indexed citations

12.

Kuter, Barbara J., Robert E. Weibel, Harry A. Guess, et al.. (1991). Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine. 9(9). 643–647. 158 indexed citations

13.

Krah, David L., Timothy Schofield, & P. J. Provost. (1990). Enhancement of varicella-zoster virus plaquing efficiency with an agarose overlay medium. Journal of Virological Methods. 27(3). 319–325. 10 indexed citations

14.

Provost, P. J., Paul M. Keller, Hilton J. Klein, et al.. (1987). Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus. Journal of Virology. 61(10). 2951–2955. 20 indexed citations

15.

Provost, P. J., Robert J. Gerety, M. R. Hilleman, et al.. (1986). New Findings in Live, Attenuated Hepatitis A Vaccine Development. Journal of Medical Virology. 20(2). 165–175. 66 indexed citations

16.

Provost, P. J., et al.. (1982). Progress toward a Live, Attenuated Human Hepatitis A Vaccine. Experimental Biology and Medicine. 170(1). 8–14. 51 indexed citations

17.

Provost, P. J., et al.. (1981). Isolation of Hepatitis A Virus in Vitro in Cell Culture Directly from Human Specimens. Experimental Biology and Medicine. 167(2). 201–206. 16 indexed citations

18.

Villarejos, V. M., et al.. (1976). Development of Immunity Against Hepatitis A Virus by Subclinical Infection. Experimental Biology and Medicine. 153(2). 205–208. 7 indexed citations

19.

Provost, P. J., B. Wolanski, William J. Miller, et al.. (1975). Biophysical and biochemical properties of CR326 human hepatitis A virus. The American Journal of the Medical Sciences. 270(1). 87–92. 6 indexed citations

20.

Provost, P. J., O. L. Ittensohn, V. M. Villarejos, & M. R. Hilleman. (1975). A Specific Complement-Fixation Test for Human Hepatitis A Employing CR326 Virus Antigen. Diagnosis and Epidemiology. Experimental Biology and Medicine. 148(4). 962–969. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact